The United States has suspended some funding for its flagship HIV/AIDS relief program, PEPFAR (President’s Emergency Plan for AIDS Relief), raising alarms among international organizations and members of Congress about the immediate impact on patients and global projects. PEPFAR, established in 2003, has been credited with saving over 26 million lives and providing antiretroviral therapy to more than 20 million people last year alone. The program also supports hundreds of thousands of health workers across more than 50 countries, strengthening healthcare systems worldwide.
The recent funding suspension follows the dismantling of USAID earlier this year and a freeze on foreign aid by the Trump administration. Although the State Department issued a waiver to exempt life-saving services, many nonprofits report that HIV/AIDS projects have been terminated or stalled. UNAIDS and other agencies have cited examples of medicine stockouts, clinic staffing cuts, suspended outreach services, and rising mortality rates in countries including Uganda, Tanzania, and the Philippines. Patients are reportedly rationing or skipping doses of antiretroviral medication, creating conditions for drug-resistant HIV strains.
Despite claims from the US government that aid work is being preserved, organizations like Doctors Without Borders and World Vision report major disruptions. Logistics for HIV care, such as transport for supplies, have largely disappeared, and key programs focused on vulnerable populations have been terminated. The lack of public data from PEPFAR, whose reporting has been delayed, further obscures the full scale of the impact. UNAIDS reported that 40% of its country offices witnessed an end to community-led services due to the funding cuts, while 30% saw international NGO services halted.
Congress is currently battling the White House over the release of the 2025 PEPFAR budget. Only about half of the $6 billion appropriated has been released, with much of the funding listed as unallocated and potentially shifted to fiscal year 2026. Bipartisan lawmakers, including Senators Susan Collins and Patty Murray, have criticized the Office of Management and Budget for obstructing funds, warning that delays will result in preventable deaths.
Meanwhile, the administration has also proposed canceling $4.9 billion in foreign aid, prompting legal challenges over the legality of withholding already approved funds. A federal judge has ruled that such rescissions require congressional approval, but the White House continues to pursue multiple avenues to delay or cancel aid. The uncertainty around funding flows has left global HIV/AIDS relief efforts at risk, threatening gains made over the past two decades in combating the epidemic.
